Table 3. . Univariate association of clinical variables with paclitaxel Tc >0.05 and Cmax.
Clinical variables | Associations with Tc >0.05 | Associations with Cmax | ||
---|---|---|---|---|
B coefficient (95% CI) | p-value | B coefficient (95% CI) | p-value | |
Age (years) | 1.00 (0.99–1.00) | 0.90 | 15.15 (1.88–28.42) | 0.026 |
BSA (m2) | 1.27 (0.96–1.68) | 0.10 | -262.77 (-1085.39–559.85) | 0.52 |
Caucasian race (vs other) | 1.22 (0.97–1.53) | 0.09 | -387.50 (-1051.95–276.95) | 0.25 |
Elevated alkaline phosphatase (vs normal) | 0.90 (0.76–1.06) | 0.22 | -83.33 (-577.99–411.32)) | 0.74 |
Elevated ALT or AST (vs normal) | 1.09 (0.90–1.32) | 0.38 | 261.13 (-294.55–816.81) | 0.35 |
Elevated albumin (vs normal) | 0.86 (0.55–1.35) | 0.52 | 356.18 (-948.61–1660.98) | 0.59 |
Prior or concurrent chemotherapy (vs none) | 1.03 (0.82–1.30) | 0.79 | -503.46 (-1260.63–253.71) | 0.19 |
Prior or concurrent HER2 therapy (vs none) | 1.02 (0.91–1.15) | 0.75 | 136.26 (-208.52–481.03) | 0.43 |
BSA: Body surface area; SD: Standard deviation.